MCBB Achieves Victory in Patent Infringement Litigation


 On March 9, 2015, Utah’s Federal District Court closed a large multi-district litigation captioned In re:  BRCA1- and BRCA2-based Hereditary Cancer Test Patent Litigation (D. Utah).  The case arose from certain patents held by Myriad Genetics, Inc., related to cancer screening tests.  In Assoc. for Molecular Pathology v. Myriad Genetics, Inc., the United States Supreme …